Novel agents in trials for AML: quizartinib and gilteritinib
At the 2018 European School of Haematology (ESH) Clinical Updates on Acute Leukaemias, held in Budapest, Hungary, Mark Levis, MD, PhD, from Sidney Kimmel Comprehensive Cancer Centre, Baltimore, MD, gi...
Author: VJHemOnc
Added: 08/02/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts